Historique
Auteur ZIEDONIS D. M.
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat à votre sélection Affiner la recherche
ZIEDONIS D. M. ; L. ZAMMARELLI ; SEWARD G. ; K. OLIVER ; J. GUYDISH ; M. HOBART ; MELTZER B. | 2007
Dans Journal of Psychoactive Drugs (Vol.39 n°4, 2007) Article : PériodiqueENGLISH : Compared to the general population, persons entering addiction treatment are three to four times more likely to be tobacco dependent and even addiction treatment staff members are two to three times more likely to be tobacco dependen[...]
M. L. STEINBERG ; J. M. WILLIAMS ; H. R. STEINBERG ; J. A. KREJCI ; ZIEDONIS D. M. | 2005
PériodiqueENGLISH : Up to 90% of individuals with schizophrenia smoke cigarettes, and many show signs of heavy dependence. Although the severity of nicotine dependence is often measured by the six-item Fagerström Test for Nicotine Dependence (FTND), thi[...]
L. AMASS ; W. LING ; T. E. FREESE ; C. REIBER ; J. J. ANNON ; A. J. COHEN ; D. McCARTY ; M. S. REID ; L. S. Jr BROWN ; C. CLARK ; ZIEDONIS D. M. ; J. KREJCI ; STINE S. ; T. WINHUSEN ; G. BRIGHAM ; D. BABCOCK ; MUIR J. A. ; B. J. BUCHAN ; T. HORTON | 2004
Dans American Journal on Addictions (Vol.13, Suppl.1, May-June 2004) Article : PériodiqueIn October 2002, the US Food and Drug Administration approved buprenorphine-naloxone (Suboxone) sublingual tablets as an opioid dependence treatment available for use outside traditionally licensed opioid treatment programs. The NIDA Center for [...]
FRANÇAIS : Il existe une liaison interactive entre la consommation de cocaïne et les troubles psychopathologiques, mais leurs manifestations sont extrêmement hétérogènes (troubles cognitifs, psychoses, anxiété, dépression). Il est important de [...]
American Psychiatric Association ; Work group on substance use disorders ; H. D. KLEBER ; R. D. WEISS ; R. F. ANTON ; T. P. GEORGE ; S. F. GREENFIELD ; T. R. KOSTEN ; OBRIEN C. P. ; B. J. ROUNSAVILLE ; E. C. STRAIN ; ZIEDONIS D. M. ; HENNESSY G. ; H. SMITH CONNERY | 2006
RapportThe Practice Guideline for the Treatment of Patients With Substance Use Disorders, 2nd Edition, consists of three parts (A, B, and C) and many sections, not all of which will be equally useful for all readers. The following guide is designed t[...]
J. M. WILLIAMS ; FOULDS J. ; M. DWYER ; ORDER-CONNORS B. ; SPRINGER M. ; GADDE P. ; ZIEDONIS D. M. | 2005
PériodiqueENGLISH : New Jersey was the first state to implement a licensure standard for all residential addiction treatment programs to assess and treat tobacco dependence in the context of entirely tobacco-free facilities (including grounds). A progra[...]
American Psychiatric Association ; Work group on substance use disorders ; Steering committee on practice guidelines ; H. D. KLEBER ; R. D. WEISS ; R. F. ANTON ; T. P. GEORGE ; S. F. GREENFIELD ; T. R. KOSTEN ; C. P. O'BRIEN ; B. J. ROUNSAVILLE ; E. C. STRAIN ; ZIEDONIS D. M. ; HENNESSY G. ; H. S. CONNERY ; J. S. McINTYRE ; S. C. CHARLES ; D. J. ANZIA ; I. A. COOK ; M. T. FINNERTY ; B. R. JOHNSON ; NININGER J. E. ; P. SUMMERGRAD ; S. M. WOODS ; YAGER J. ; PYLES R. ; C. D. CROSS ; R. PEELE ; SHEMO J. P. ; L. LURIE ; R. D. WALKER ; M. A. BARNOVITZ ; S. H. GRAY ; S. SAXENA ; TONNU T. ; KUNKLE R. ; A. B. ALBERT ; FOCHTMANN L. J. ; C. HART ; D. REGIER | 2007
Dans American Journal of Psychiatry (Vol.164, n°4 Suppl., 2007) Article : PériodiqueIndividuals with substance use disorders are heterogeneous with regard to a number of clinically important features and domains of functioning. Consequently, a multimodal approach to treatment is typically required. Care of individuals with subs[...]
